CenterBook Partners
MRVI icon

CenterBook Partners’s Maravai LifeSciences MRVI Stock Holding History

CenterBook Partners’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-55,910
Closed -$349K – 976
2026
Q2 		$349K Buy
+55,910
New +$241K 0.02% 603
2025
Q4 		– Sell
-1,691,873
Closed -$4.86M – 641
2025
Q3 		$4.86M Buy
1,691,873
+57,365
+4% +$146K 0.24% 112
2025
Q2 		$3.94M Buy
1,634,508
+276,908
+20% +$582K 0.22% 124
2025
Q1 		$3M Buy
1,357,600
+545,674
+67% +$2.16M 0.19% 138
2024
Q4 		$4.42M Buy
+811,926
New +$5.22M 0.26% 114

Other funds holding MRVI

General American Investors
General American Investors New York $1.71B AUM 30.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Torrey Growth & Income Advisors
Torrey Growth & Income Advisors Del Mar, California $297M AUM 36.15% 1-Year Est. Return
Arizona State Retirement System
Arizona State Retirement System Phoenix, Arizona $20.3B AUM 36.55% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

CenterBook Partners's MRVI Position: Q3 2026 in Review

CenterBook Partners sold out of Maravai LifeSciences (MRVI) in Q3 2026, closing a stake of 55,910 shares — an estimated $349K sold.

CenterBook Partners first reported a position in MRVI in Q4 2024 and held it in 5 quarters. The position peaked at $4.86M in Q3 2025. 46 funds tracked by Wall St. Rank hold MRVI as of Q3 2026.

  • CenterBook Partners reported no remaining Maravai LifeSciences position as of Q3 2026 after selling out during the quarter.
  • CenterBook Partners sold 55,910 Maravai LifeSciences shares in Q3 2026, an estimated $349K.
  • CenterBook Partners first reported a position in Maravai LifeSciences in Q4 2024 and held it in 5 quarters.
  • CenterBook Partners's Maravai LifeSciences position peaked at $4.86M in Q3 2025.
  • 46 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2026.

Based on CenterBook Partners's 13F filing for Q3 2026, filed 2 Nov 2026.